849799-31-1

Basic information

• Product Name: ((2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-methoxy-tetrahydro-pyran-2-yl)-methanesulfonic acid 4-{(2S,3R)-1-(4-fluoro-phenyl)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-4-oxo-azetidin-2-yl}-phenyl ester
• Synonyms: ((2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-methoxy-tetrahydro-pyran-2-yl)-methanesulfonic acid 4-{(2S,3R)-1-(4-fluoro-phenyl)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-4-oxo-azetidin-2-yl}-phenyl ester
• CAS NO: 849799-31-1
• Molecular Weight: 649.667
• Mol File: 849799-31-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ((2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-methoxy-tetrahydro-pyran-2-yl)-methanesulfonic acid 4-{(2S,3R)-1-(4-fluoro-phenyl)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-4-oxo-azetidin-2-yl}-phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: ((2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-methoxy-tetrahydro-pyran-2-yl)-methanesulfonic acid 4-{(2S,3R)-1-(4-fluoro-phenyl)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-4-oxo-azetidin-2-yl}-phenyl ester(849799-31-1)
• EPA Substance Registry System: ((2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-methoxy-tetrahydro-pyran-2-yl)-methanesulfonic acid 4-{(2S,3R)-1-(4-fluoro-phenyl)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-4-oxo-azetidin-2-yl}-phenyl ester(849799-31-1)

Safety Data

• Hazardous Substances Data: 849799-31-1(Hazardous Substances Data)

Upstream product

• 163222-33-1 ezetemibe 
• 849799-29-7 ((2S,3S,4S,5R,6S)-3,4,5-Tris-benzyloxy-6-methoxy-tetrahydro-pyran-2-yl)-methanesulfonic acid 4-[(2S,3R)-3-[(S)-3-(tert-butyl-dimethyl-silanyloxy)-3-(4-fluoro-phenyl)-propyl]-1-(4-fluoro-phenyl)-4-oxo-azetidin-2-yl]-phenyl ester 
• 795306-55-7 Acetic acid 4-[(2S,3R)-3-[(S)-3-(tert-butyl-dimethyl-silanyloxy)-3-(4-fluoro-phenyl)-propyl]-1-(4-fluoro-phenyl)-4-oxo-azetidin-2-yl]-phenyl ester 
• 795306-57-9 3′-(S)-4-(S)-3-(R)-[3′-t-butyldimethylsilyloxy-3′-(4-fluorophenyl)propyl]-4-(4-hydroxyphenyl)-1-(4-fluorophenyl)azetidin-2-one 
• 795306-53-5 Acetic acid 4-{(2S,3R)-1-(4-fluoro-phenyl)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-4-oxo-azetidin-2-yl}-phenyl ester 
• 849799-28-6 ((2S,3S,4S,5R,6S)-3,4,5-Tris-benzyloxy-6-methoxy-tetrahydro-pyran-2-yl)-methanesulfonyl chloride 
• 849799-30-0 ((2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-methoxy-tetrahydro-pyran-2-yl)-methanesulfonic acid 4-[(2S,3R)-3-[(S)-3-(tert-butyl-dimethyl-silanyloxy)-3-(4-fluoro-phenyl)-propyl]-1-(4-fluoro-phenyl)-4-oxo-azetidin-2-yl]-phenyl ester 

Relevant articles and documents

Novel hypocholesterolemic compounds

The present invention relates to novel hypocholesterolemic compounds of formula I useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels as well as to pharmaceutical compositions comprising said compounds alo

Synthesis and in vitro evaluation of inhibitors of intestinal cholesterol absorption

We have utilized our recently developed in vitro assay to address two key questions in the design of small-molecule cholesterol absorption inhibitors using ezetimibe, the only drug yet approved for the inhibition of cholesterol absorption in the small int